Genitourinary Cancer,Prostate Cancer Comparing ENZA + TALA to Placebo + ENZA in Treating mCRPC Mar 27, 2023
Genitourinary Cancer,Prostate Cancer PROs of Pembrolizumab + Olaparib Treatment in Patients with mCRPC Mar 27, 2023
Genitourinary Cancer,Prostate Cancer Efficacy and Safety of Pembrolizumab and Docetaxel for mCRPC Mar 27, 2023
Genitourinary Cancer,Prostate Cancer TALA Efficacy vs. Placebo with ENZA in First-Line mCRPC Treatment Mar 27, 2023
Genitourinary Cancer,Prostate Cancer Interim Analysis 2 of NIRA + AAP for Treating mCRPC Patients Mar 27, 2023
Genitourinary Cancer,Prostate Cancer Overall Survival of Abi+Ola vs. Abi+Pbo in 1st Line mCRPC Mar 27, 2023
Genitourinary Cancer,Prostate Cancer Darolutamide vs. Docetaxel for Treating mHSPC by Disease Volume and Risk Mar 27, 2023
